Royce & Associates’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-663,010
Closed -$7.47M 788
2025
Q2
$7.47M Buy
663,010
+92,130
+16% +$846K 0.08% 372
2025
Q1
$5.41M Sell
570,880
-5,320
-0.9% -$53.7K 0.06% 432
2024
Q4
$6.48M Buy
576,200
+326,200
+130% +$5.73M 0.06% 427
2024
Q3
$7.07M Buy
+250,000
New +$6.44M 0.06% 407
2021
Q4
Sell
-310,036
Closed -$9.61M 979
2021
Q3
$9.61M Sell
310,036
-105,775
-25% -$2.54M 0.07% 423
2021
Q2
$8.78M Sell
415,811
-57,500
-12% -$1.15M 0.06% 460
2021
Q1
$9.56M Sell
473,311
-94,000
-17% -$1.79M 0.06% 456
2020
Q4
$9.09M Sell
567,311
-91,000
-14% -$1.2M 0.08% 397
2020
Q3
$8.17M Sell
658,311
-67,500
-9% -$794K 0.09% 339
2020
Q2
$5.17M Buy
725,811
+192,400
+36% +$1.29M 0.06% 447
2020
Q1
$2.9M Buy
533,411
+62,000
+13% +$554K 0.04% 509
2019
Q4
$4.27M Sell
471,411
-521,000
-52% -$4.23M 0.04% 529
2019
Q3
$7.13M Buy
992,411
+265,811
+37% +$1.91M 0.07% 389
2019
Q2
$5.78M Buy
726,600
+305,000
+72% +$3.61M 0.05% 458
2019
Q1
$5.3M Buy
421,600
+315,600
+298% +$5M 0.04% 494
2018
Q4
$2.12M Buy
+106,000
New +$2.45M 0.02% 716

Other funds holding EVH